14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALLO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Allogene Therapeutics stock price up 1.71% on Thursday
(Updated on May 02, 2024)

Sell candidate since Mar 25, 2024 Loss -30.77% PDF

The Allogene Therapeutics stock price gained 1.71% on the last trading day (Thursday, 2nd May 2024), rising from $2.92 to $2.97. During the last trading day the stock fluctuated 5.82% from a day low at $2.92 to a day high of $3.09. The price has fallen in 6 of the last 10 days and is down by -14.16% for this period. Volume fell on the last day by -1 million shares and in total, 1 million shares were bought and sold for approximately $4.16 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.70 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -29.65% during the next 3 months and, with a 90% probability hold a price between $1.90 and $3.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALLO Signals & Forecast

There are mixed signals in the stock today. The Allogene Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.81. On a fall, the stock will find some support from the short-term average at $2.90. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 7.61%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Allogene Therapeutics stock

Allogene Therapeutics finds support from accumulated volume at $2.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 5.82%. For the last week, the stock has had daily average volatility of 8.32%.

Allogene Therapeutics is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALLO) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Allogene Therapeutics Inc. to open at $2.99, and during the day (based on 14 day Average True Range), to move between $2.72 and $3.22, which gives a possible trading interval of +/-$0.246 (+/-8.28%) up or down from last closing price. If Allogene Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 16.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.92 (1.68%) than the resistance at $3.04 (2.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Allogene Therapeutics Inc. stock A Buy?

Allogene Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.825 Sell Candidate Unchanged

Predicted Opening Price for Allogene Therapeutics Inc. of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$2.99 ( 0.786%) $2.97

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALLO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.16 6.51 %
R2 3.10 4.32 %
R1 3.06 2.97 %
Current price: 2.97
Support S1 2.93 -1.40 %
S2 2.89 -2.75 %
S3 2.82 -4.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.51 18.18 %
R2 3.47 16.84 %
R1 3.04 2.36 %
Current price 2.97
Support S1 2.92 -1.68%
S2 2.86 -3.87%
S3 2.84 -4.38%

FAQ

What is the symbol for Allogene Therapeutics Stock and on which exchange is it traded?
The symbol for Allogene Therapeutics is ALLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Allogene Therapeutics Stock?
Allogene Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Allogene Therapeutics Stock?
Allogene Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Allogene Therapeutics Stock.

What's the current price of Allogene Therapeutics Stock?
As of the end of day on the May 02, 2024, the price of an Allogene Therapeutics (ALLO) share was $2.97.

What is the 52-week high and low for Allogene Therapeutics Stock?
The 52-week high for Allogene Therapeutics Stock is $6.89 and the 52-week low is $2.23.

What is the market capitalization of Allogene Therapeutics Stock?
As of the May 02, 2024, the market capitalization of Allogene Therapeutics is 507.047M.

When is the next earnings date for Allogene Therapeutics?
The upcoming earnings date for Allogene Therapeutics is Jul 31, 2024.
Click to get the best stock tips daily for free!

About Allogene Therapeutics Inc.

Allogene Therapeutics Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic ... ALLO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT